<DOC>
	<DOCNO>NCT01198717</DOCNO>
	<brief_summary>The aim study evaluate progression ET child ( age 6-17years inclusive ) period 5 year maximum . The study also assess child diagnose , treatment option child symptom event related ET outcomes treatment .</brief_summary>
	<brief_title>Pediatric Disease Registry Essential Thrombocythaemia ( ET )</brief_title>
	<detailed_description />
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Thrombocythemia , Essential</mesh_term>
	<criteria>6 year less 18 year patient ET accord WHO criteria guidance Interventional clinical study participation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>